Glaucoma device showdown ends early: only 10 patients enrolled
NCT ID NCT04658095
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 31 times
Summary
This study aimed to compare two surgical devices—the OMNI system and the iStent inject—for lowering eye pressure in people with open-angle glaucoma who already had cataract surgery. The trial was terminated early and only enrolled 10 participants, so results are limited. Both devices are designed to help control glaucoma, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN-ANGLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BurgerHospital
Frankfurt, Germany
-
Institut Catala de Retina (ICR)
Barcelona, 08022, Spain
-
Manchester Royal Eye Hospital
Manchester, M13, United Kingdom
-
Paseo Isabel la Católica 1-3. Edificio general Hospital Miguel Servet. Planta calle
Zaragoza, 50009, Spain
-
Universidad Complutense de Madrid
Valencia, 46026, Spain
Conditions
Explore the condition pages connected to this study.